Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics
J.G. Luz(Center Point), Matthew J. Fisher(Eli Lilly (United States)), Stephen Antonysamy(Eli Lilly (United States)), Ryan T. Backer(Eli Lilly (United States)), Bradley Condon(Center Point), Steven L. Kuklish(Eli Lilly (United States)), Ashley V. Sloan(Eli Lilly (United States)), Marijane Russell(Center Point), Matthew R. Lee(Center Point), Aiping Zhang(Yangzhou University), Srinivasan Chandrasekhar(Eli Lilly (United States)), Anita K. Harvey(Eli Lilly (United States)), Xiaopeng Yu(Hunan University of Traditional Chinese Medicine), Dagart Allison(Center Point), Shawn S. Chang(Center Point)
Cited by 66
Related Papers
Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
|International Journal of Biological Sciences|2022|350
The 2.5 Å Crystal Structure of the SIRT1 Catalytic Domain Bound to Nicotinamide Adenine Dinucleotide (NAD<sup>+</sup>) and an Indole (EX527 Analogue) Reveals a Novel Mechanism of Histone Deacetylase Inhibition
|Journal of Medicinal Chemistry|2013|218
A Multicenter Application and Evaluation of the Oxford Classification of IgA Nephropathy in Adult Chinese Patients
|American Journal of Kidney Diseases|2012|157
Quantitative Proteomic Analyses of Human Cytomegalovirus-Induced Restructuring of Endoplasmic Reticulum-Mitochondrial Contacts at Late Times of Infection
|Molecular & Cellular Proteomics|2011|120